Patents by Inventor Masami Yamada

Masami Yamada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9641713
    Abstract: A power-saving mode deactivation apparatus for performing communication via a communication network with specific processing apparatuses for particular processing is provided. The power-saving mode deactivation apparatus includes a storage portion for storing therein a deactivation method for deactivating a power-saving mode of each of the specific processing apparatuses; a detection portion for detecting that particular processing data for the particular processing is not delivered to, among the specific processing apparatuses, a destination specific processing apparatus of the particular processing data, and a deactivation portion for performing, when the detection portion detects that the particular processing data is not delivered to the destination specific processing apparatus, deactivation processing for deactivating a power-saving mode of the destination specific processing apparatus based on the deactivation method, stored in the storage portion, for the destination specific processing apparatus.
    Type: Grant
    Filed: August 27, 2012
    Date of Patent: May 2, 2017
    Assignee: KONICA MINOLTA BUSINESS TECHNOLOGIES, INC.
    Inventors: Atsushi Ohshima, Keisuke Teramoto, Masami Yamada, Yoshiaki Shibuta, Hiroaki Kubo
  • Publication number: 20170100373
    Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
    Type: Application
    Filed: December 22, 2016
    Publication date: April 13, 2017
    Inventors: Masami YAMADA, Shinkichi SUZUKI, Takahiro SUGIMOTO, Minoru NAKAMURA, Hiroki SAKAMOTO, Makoto KAMATA
  • Publication number: 20170100384
    Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
    Type: Application
    Filed: December 22, 2016
    Publication date: April 13, 2017
    Inventors: Masami YAMADA, Shinkichi SUZUKI, Takahiro SUGIMOTO, Minoru NAKAMURA, Hiroki SAKAMOTO, Makoto KAMATA
  • Patent number: 9606757
    Abstract: A controller of a management device managing a plurality of image processing apparatuses acquires ability information and device identification information from the respective image processing apparatuses; determines, based on the ability information of the respective image processing apparatuses, as an in-charge device any one of the respective image processing apparatuses for each of a plurality of protocols predetermined; for the respective protocols, causes the in-charge device determined for the protocol to respond to a packet by multicast of the protocol on behalf of the respective image processing apparatuses; and causes one or more image processing apparatuses other than the in-charge device determined for the protocol to refrain from responding to a packet by multicast of the protocol. The respective image processing apparatuses respond to a packet by multicast of the protocol if the apparatus itself is determined the in-charge device for the protocol.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: March 28, 2017
    Assignee: KONICA MINOLTA, INC.
    Inventors: Masami Yamada, Kazumi Sawayanagi, Hisashi Uchida, Kazuya Anezaki, Akihiro Torigoshi, Yasutaka Ito
  • Publication number: 20170081332
    Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as medicaments such as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like, and the like. The present invention relates to a compound represented by the formula (I) wherein ring A is an optionally substituted 5- or 6-membered ring; R is a C1-6 alkyl group substituted by 1 to 5 halogen atoms; and X is —CH? or —N?, or a salt thereof.
    Type: Application
    Filed: May 15, 2015
    Publication date: March 23, 2017
    Inventors: Takahiro SUGIMOTO, Kenichiro SHIMOKAWA, Takuto KOJIMA, Hiroki SAKAMOTO, Ikuo FUJIMORI, Minoru NAKAMURA, Masami YAMADA, Masataka MURAKAMI, Makoto KAMATA, Shinkichi SUZUKI
  • Patent number: 9578084
    Abstract: An information processing system comprises a user terminal and an information processing device. A remote operation screen image for remotely operating the information processing device is displayed with the user terminal so that the information processing device is operated by remote control via the user terminal. The information processing device includes: a screen image controlling part for receiving operation information from the user terminal; a contents determining part for determining if contents accessed by a browser are internal contents of the information processing device when the operation information is a process request requiring start up of the browser; and a browser controlling part for starting up a first browser on the information processing device when the internal contents are to be accessed, and sending a browser start up instruction to cause start up of a second browser installed on the user terminal when external contents are to be accessed.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: February 21, 2017
    Assignee: KONICA MINOLTA BUSINESS TECHNOLOGIES, INC.
    Inventors: Daisuke Sakiyama, Masami Yamada, Atsushi Ohshima, Keisuke Teramoto, Atsushi Tamura, Yukina Hisada
  • Publication number: 20170044143
    Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. (I) wherein each symbol is as described in the specification, or a salt thereof.
    Type: Application
    Filed: April 22, 2015
    Publication date: February 16, 2017
    Applicant: Takeda Phamaceutical Company Limited
    Inventors: Masami YAMADA, Shinkichi SUZUKI, Takahiro SUGIMOTO, Minoru NAKAMURA, Hiroki SAKAMOTO, Makoto KAMATA
  • Patent number: 9569145
    Abstract: A gateway apparatus connected to an image processing apparatus in a communicable manner and connected to an external apparatus via a network, and performing communication control between the image processing apparatus and the external apparatus, includes: a main CPU; a sub CPU; a first detecting unit configured to detect a state of a primary power supply; a second detecting unit configured to detect a state of a secondary power supply; a generating unit configured to generate a transfer instruction message; an acquiring unit configured to acquire information about a change in a state of the gateway apparatus or an apparatus located in the vicinity of the gateway apparatus; an updating unit configured to repeatedly perform updating of the transfer instruction message; and a transmitting unit configured to transmit the last-generated or last-updated transfer instruction message to an external alternate apparatus.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: February 14, 2017
    Assignee: KONICA MINOLTA, INC.
    Inventors: Hisashi Uchida, Kazumi Sawayanagi, Masami Yamada, Kazuya Anezaki, Akihiro Torigoshi, Yasutaka Ito
  • Patent number: 9563389
    Abstract: An image processing system includes: a server apparatus connected to a first network; an image processing apparatus connected to a second network; and a gateway apparatus, wherein the server apparatus includes: a transmitting unit configured to transmit job data of a job by the first communication protocol, the image processing apparatus being made to execute the job; and an adding unit configured to add content information to the job data, the content information indicating contents of the job, and the gateway apparatus includes: an analyzing unit; a determining unit; and an executing unit.
    Type: Grant
    Filed: March 24, 2015
    Date of Patent: February 7, 2017
    Assignee: KONICA MINOLTA, INC.
    Inventors: Kazuya Anezaki, Kazumi Sawayanagi, Masami Yamada, Hisashi Uchida, Akihiro Torigoshi, Yasutaka Ito
  • Publication number: 20170027921
    Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
    Type: Application
    Filed: October 12, 2016
    Publication date: February 2, 2017
    Inventors: Masami YAMADA, Shinkichi SUZUKI, Takahiro SUGIMOTO, Minoru NAKAMURA, Hiroki SAKAMOTO, Makoto KAMATA
  • Patent number: 9549096
    Abstract: An image processing system includes: an application server located in the Internet; an image processing apparatus located in a local network connected to the Internet via a firewall; a relay server configured to relay communication between the image processing apparatus and the application server, the relay server being located in the local network; and a connection mediation server configured to transmit, to the relay server, a request for a connection to the application server, the connection mediation server being located in the Internet, wherein the connection mediation server includes a connection request transmitting unit so as to have communication established between the image processing apparatus and the application server, the relay server includes: a communication establishing unit; a job transferring unit; a job identifying unit; and a communication terminating unit, and after the communication terminating unit terminates the communication, the communication establishing unit reestablishes the com
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: January 17, 2017
    Assignee: Konica Minolta, Inc.
    Inventors: Akihiro Torigoshi, Kazumi Sawayanagi, Masami Yamada, Hisashi Uchida, Kazuya Anezaki, Yasutaka Ito
  • Publication number: 20170006178
    Abstract: An image forming apparatus includes: a first communication unit configured to perform communication by a short-distance wireless method; a second communication unit having a broader communication range than the first communication unit; a storage unit configured to store data to which an access right of a first user is set; a connection information providing unit configured to, when a data providing command for providing the data from a first terminal device of the first user to another user is received, and an access request to the data is received from a second terminal device of a second user, transmit connection information for accessing the data to the second terminal device; and a data providing unit configured to transmit the data to the second terminal device by the second communication unit, when a transmission request of the data is received from the second terminal device based on the connection information.
    Type: Application
    Filed: June 21, 2016
    Publication date: January 5, 2017
    Applicant: KONICA MINOLTA, INC.
    Inventors: Masami YAMADA, Atsushi OHSHIMA, Takeshi MAEKAWA, Kenichi TAKAHASHI, Masaya HASHIMOTO
  • Publication number: 20160376244
    Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof: wherein each symbol is as defined in the attached DESCRIPTION.
    Type: Application
    Filed: June 23, 2016
    Publication date: December 29, 2016
    Inventors: Takahiro SUGIMOTO, Shinkichi SUZUKI, Hiroki SAKAMOTO, Masami YAMADA, Minoru NAKAMURA, Makoto KAMATA, Kenichiro SHIMOKAWA, Masaki OGINO, Eiji KIMURA, Masataka MURAKAMI, Jinichi YONEMORI, Takuto KOJIMA
  • Patent number: 9518042
    Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
    Type: Grant
    Filed: February 2, 2016
    Date of Patent: December 13, 2016
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Masami Yamada, Shinkichi Suzuki, Takahiro Sugimoto, Minoru Nakamura, Hiroki Sakamoto, Makoto Kamata
  • Patent number: 9499516
    Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
    Type: Grant
    Filed: February 2, 2016
    Date of Patent: November 22, 2016
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Masami Yamada, Shinkichi Suzuki, Takahiro Sugimoto, Minoru Nakamura, Hiroki Sakamoto, Makoto Kamata
  • Publication number: 20160152603
    Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
    Type: Application
    Filed: February 2, 2016
    Publication date: June 2, 2016
    Inventors: Masami YAMADA, Shinkichi SUZUKI, Takahiro SUGIMOTO, Minoru NAKAMURA, Hiroki SAKAMOTO, Makoto KAMATA
  • Publication number: 20160152598
    Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
    Type: Application
    Filed: February 2, 2016
    Publication date: June 2, 2016
    Inventors: Masami YAMADA, Shinkichi SUZUKI, Takahiro SUGIMOTO, Minoru NAKAMURA, Hiroki SAKAMOTO, Makoto KAMATA
  • Patent number: 9315458
    Abstract: The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity and useful as an agent for the prophylaxis or treatment of Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies, and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof. wherein each symbol is as described in the specification, or a salt thereof.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: April 19, 2016
    Assignee: Takeda Pharmaceutical Company, Limited
    Inventors: Masami Yamada, Shinkichi Suzuki, Takahiro Sugimoto, Minoru Nakamura, Hiroki Sakamoto, Makoto Kamata
  • Patent number: 9313369
    Abstract: A shared data managing device is provided which manages shared data by setting an access right on a first user account basis. The first user account has a first identifier and first user information on a first user receiving a first service. The device includes an obtaining portion for obtaining, from a service providing system for a second service, a second identifier of a second user account used for the second service and second user information on a second user; a pairing portion for making a pair of the first identifier and the second identifier of the first user account and the second user account that are common in the first user information and the second user information; and a transmission portion for sending, to the service providing system, the shared data, the pair made, and the access right on a first user account basis.
    Type: Grant
    Filed: May 29, 2014
    Date of Patent: April 12, 2016
    Assignee: Konica Minolta, Inc.
    Inventors: Shuji Yoneda, Kenichi Takahashi, Kaitaku Ozawa, Nobuhiro Mishima, Masami Yamada, Yuki Asai
  • Patent number: 9264563
    Abstract: A communication system includes a plurality of devices, a plurality of communication relay apparatuses, and a management server. If the management server that has received from a cloud server a request to access a specific device has no communication session with a specific communication relay apparatus that has control over the specific device, the management server transmits a tunnel connection request to a substitute apparatus (another communication relay apparatus different from the specific communication relay apparatus) via a communication session between the substitute apparatus and the management server. The substitute apparatus transfers the tunnel connection request to the specific communication relay apparatus and causes the specific communication relay apparatus to return from a power saving mode.
    Type: Grant
    Filed: December 11, 2014
    Date of Patent: February 16, 2016
    Assignee: KONICA MINOLTA, INC.
    Inventors: Kazuya Anezaki, Kazumi Sawayanagi, Masami Yamada, Shuji Yoneda, Hisashi Uchida, Akihiro Torigoshi, Yasutaka Ito